Papel del tratamiento antihipertensivo en la prevención de la insuficiencia cardiaca

2003, 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension, J Hypertens, 21, 1011, 10.1097/00004872-200306000-00001 Chobanian, 2003, The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report, JAMA, 289, 2560, 10.1001/jama.289.19.2560 Ramsay, 2004, Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004-BHS IV, J Hum Hypertens, 18, 139, 10.1038/sj.jhh.1001683 Khan, 2004, The 2004 Canadian recommendations for the management of hypertension: Part II-Therapy, Can J Cardiol, 20, 41 2005, Hipertensión, 22, s1 MacMahon, 1990, Blood Pressure, stroke, and coronary heart disease. Part 1: Prolonged differences in blood pressure. Prospective observational studies corrected for the regression dilution bias, Lancet, 355, 765, 10.1016/0140-6736(90)90878-9 1990, Mortality after 10 years for hypertensive participants in the Multiple Risk Factor Intervention Trial, Circulation, 82, 1616, 10.1161/01.CIR.82.5.1616 Stamler, 1993, Blood pressure, systolic and diastolic, and cardiovascular risks: US population Data, Arch Intern Med, 153, 598, 10.1001/archinte.1993.00410050036006 Hansson, 1998, Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial, Lancet, 351, 1755, 10.1016/S0140-6736(98)04311-6 2003, 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension, J Hypertens, 21, 1983, 10.1097/00004872-200311000-00002 Lombera, 2000, Guías de práctica clínica de la Sociedad Española de Cardiología en hipertensión arterial, Rev Esp Cardiol, 53, 66, 10.1016/S0300-8932(00)75065-2 1972, Effects of treatment on mortality in hypertension III. Influence of age, diastolic blood pressure, and prior cardiovascular disease; further analysis of side effects, Circulation, 45, 991, 10.1161/01.CIR.45.5.991 1979, Five-year findings of the Hypertension Detection and Follow-up Program. I. Reduction in mortality of persons with high blood pressure, including mild hypertension, JAMA, 242, 2562, 10.1001/jama.1979.03300230018021 Amery, 1985, Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly Trial, Lancet, 1, 1349, 10.1016/S0140-6736(85)91783-0 Coope, 1986, Randomised trial of treatment of hypertension in elderly patients in primary care, BMJ, 293, 1145, 10.1136/bmj.293.6555.1145 Dahlöf, 1991, Morbidity and mortality in the Swedish trial in old patients with hypertension (STOP-hypertension), Lancet, 338, 1281, 10.1016/0140-6736(91)92589-T 1992, Medical Research Council trial of treatment of hypertension in older adults: principal results, BMJ, 304, 405, 10.1136/bmj.304.6824.405 Hansson, 1999, Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity in the Swedish Trial in Old Patients with Hypertension-2 study, Lancet, 354, 1751, 10.1016/S0140-6736(99)10327-1 1991, Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the systolic hypertension in the Elderly Program (SHEP), JAMA, 265, 3255, 10.1001/jama.1991.03460240051027 Staessen, 1997, Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension, Lancet, 350, 757, 10.1016/S0140-6736(97)05381-6 Liu, 1998, Comparison of active treatment and placebo in older chinese patients with isolated systolic hypertension, J Hypertens, 16, 1823, 10.1097/00004872-199816120-00016 Somes, 1999, The role of diastolic blood pressure when treating isolated systolic hypertension, Arch Intern Med, 159, 2004, 10.1001/archinte.159.17.2004 Staessen, 2003, Cardiovascular prevention and blood pressure reduction: a quantitative overview updated until 1 March 2003, J Hypertens, 21, 1055, 10.1097/00004872-200306000-00002 2003, Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomized trials, Lancet, 362, 1527, 10.1016/S0140-6736(03)14739-3 2002, Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic, JAMA, 288, 2981, 10.1001/jama.288.23.2981 Swedberg, 2005, Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005). The task force for the diagnosis and treatment of chronic heart failure of the European Society of Cardiology, Eur Heart J, 26, 1115, 10.1093/eurheartj/ehi204 Hunt S, and writing committee members ACC/AHA 2005 Guideline update for the diagnosis and management of chronic Heart failure in the adult. A report of the American College of Cardiology/American Heart Association task force on practice guidelines, 2005. Maurer, 2004, Can it be diagnosed by doppler echocardiography?, J Am Coll Cardiol, 44, 1543, 10.1016/j.jacc.2004.07.034 Aurigemma, 2004, Diastolic heart failure, N Engl J Med, 351, 1097, 10.1056/NEJMcp022709 Sacha, 2006, Outcome of heart failure with preserved ejection fraction I a population-based study, N Engl J Med, 355, 260, 10.1056/NEJMoa051530 Varela-Roman, 2002, Clinical characteristics and prognosis of hospitalized inpatients with heart failure and preserved or reduced left ventricular ejection fraction, Heart, 88, 249, 10.1136/heart.88.3.249 Wu, 2005, Management of diastolic heart failure: a practical review of pathophysiology and treatment trial data, Int J Clin Pract, 59, 1239, 10.1111/j.1368-5031.2005.00642.x Cleland, 2006, The perindopril in elderly people with chronic heart failure (PEP-CHF) study, Eur Heart J, 27, 2338, 10.1093/eurheartj/ehl250 López, 2004, Effects of loop diuretics on myocardial fibrosis and collagen type I turnover in chronic heart failure, J Am Coll Cardiol, 43, 2028, 10.1016/j.jacc.2003.12.052 Cook, 2006, High heart rate: a cardiovascular risk factor?, Eur Heart J, 27, 2387, 10.1093/eurheartj/ehl259 Aronow, 1997, Effect of propranolol vs no propranolol on total mortality plus nonfatal myocardial infarction in older patients with prior myocardial infarction, congestive heart failure and left ventricular ejection fraction ≥ 40% treated with diuretics plus ACEI, Am J Cardiol, 80, 207, 10.1016/S0002-9149(97)00320-2 Setaro, 1990, Usefulness of verapamil for congestive heart failure associated with abnormal left ventricular diastolic filling and normal left ventricular systolic performance, Am J Cardiol, 66, 981, 10.1016/0002-9149(90)90937-V Pfeffer, 2003, Effects of candesartan on mortality and morbidity in patients with chronic heart failure: The CHARM overall programme, Lancet, 362, 759, 10.1016/S0140-6736(03)14282-1 Arias, 2005, Obstructive sleep apnea syndrome affects left ventricular diastolic function. Effects of nasal continuous positive airway pressure in men, Circulation, 112, 375, 10.1161/CIRCULATIONAHA.104.501841 Flather, 2000, Lancet, 355, 1575, 10.1016/S0140-6736(00)02212-1 1987, Effects of enalapril on mortality in severe heart failure, N Engl J Med, 316, 1429, 10.1056/NEJM198706043162301 1991, Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure, N Engl J Med, 325, 293, 10.1056/NEJM199108013250501 1992, Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions, N Engl J Med, 327, 685, 10.1056/NEJM199209033271003 Pfeffer, 1992, Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: results of the survival and ventricular enlargement trial, N Engl J Med, 327, 669, 10.1056/NEJM199209033271001 1997, Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure, Lancet, 342, 821 Kober, 1995, A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction, N Engl J Med, 333, 1670, 10.1056/NEJM199512213332503 Packer, 1996, The effect of carvedilol on morbidity and mortality in patients with chronic heart failure, N Engl J Med, 334, 1349, 10.1056/NEJM199605233342101 Packer, 2001, Effect of carvedilol on survival in severe chronic heart failure. COPERNICUS trial, N Engl J Med, 344, 1651, 10.1056/NEJM200105313442201 1999, The cardiac insufficiency bisoprolol study II (CIBIS-II): a randomized trial, Lancet, 353, 9, 10.1016/S0140-6736(98)11181-9 1999, Effect of metoprolol CR/XL in chronic heart failure: metoprolol CR/XL randomized intervention trial in congestive heart failure (MERIT-HF), Lancet, 353, 2001, 10.1016/S0140-6736(99)04440-2 Flather, 2005, FASTRACK Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS), Eur Heart J, 26, 215, 10.1093/eurheartj/ehi115 Pfeffer, 2003, Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction or both, N Engl J Med, 349, 1893, 10.1056/NEJMoa032292 Wong, 2002, Valsartan benefits left ventricular structure and function in heart failure: Val-Heft echocardiographic study, J Am Coll Cardiol, 40, 970, 10.1016/S0735-1097(02)02063-6 Cosín, 2002, Torasemide in chronic heart failure: results of the TORIC study, Eur J Heart Fail, 4, 507, 10.1016/S1388-9842(02)00122-8 Pitt, 1999, The effect of spironolactone on morbidity and mortality in patients with severe heart failure, N Engl J Med, 341, 709, 10.1056/NEJM199909023411001 Pitt, 2003, Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study Investigators. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction, N Engl J Med, 348, 1309, 10.1056/NEJMoa030207 Gheorghiade, 2003, Vasopresin V2-receptor blockade with tolvaptan in patients with chronic heart failure: results from a doubleblind randomized trial, Circulation, 107, 2690, 10.1161/01.CIR.0000070422.41439.04 1997, The effect of digoxin on mortality and morbidity in patients with heart failure, N Engl J Med, 336, 525, 10.1056/NEJM199702203360801 Adams, 2002, Clinical benefits of low serum digoxin concentrations in heart failure, J Am Coll Cardiol, 39, 946, 10.1016/S0735-1097(02)01708-4 Cohn, 1986, Effect of vasodilator therapy on mortality in chronic congestive heart failure: results of a Veterans Administration Cooperative Study, N Engl J Med, 314, 1547, 10.1056/NEJM198606123142404 Cohn, 1991, A comparison of enalapril, hydralazine plus isosorbide dinitrate in the treatment of chronic congestive heart failure, N Engl J Med, 325, 303, 10.1056/NEJM199108013250502 Taylor, 2004, Combination of isosobide dinitrate and hydralazine in blacks with heart failure, N Engl J Med, 351, 2049, 10.1056/NEJMoa042934 Cohn, 1997, Effect of calcium antagonist felodipine as supplementary vasodilator therapy in patients with chronic heart failure treated with enalapril: V-HeFT III. Vasodilator-Heart Failure Trial (V-HeFT) Study Group, Circulation, 96, 856, 10.1161/01.CIR.96.3.856 Thackray, 2000, Clinical trials update: Optime,-CHF, PRAISE-2, ALL-HAT, Eur J Heart Fail, 2, 209, 10.1016/S1388-9842(00)00080-5